Sessions(by Program Type)

Advanced Search

Symposium

[D1-A1]Opening Remarks

Mon. Mar 3, 2025 12:30 PM - 12:50 PM JST
Mon. Mar 3, 2025 3:30 AM - 3:50 AM UTC

Medium Hall(2nd Floor)

[D1-A2]Quantitative Proteomics and its Application to Biomarker Research

Mon. Mar 3, 2025 12:50 PM - 2:30 PM JST
Mon. Mar 3, 2025 3:50 AM - 5:30 AM UTC

Medium Hall(2nd Floor)

Chairman:Eiichi Shimada(Ono Pharmaceuticals Co., Ltd.), Tomofumi Ohyama(Toray Research Center, Inc.)

[D1-A3]After the implementation of ICH-M10 guideline: Questions and concerns in the real bioanalytical field

Mon. Mar 3, 2025 4:00 PM - 5:00 PM JST
Mon. Mar 3, 2025 7:00 AM - 8:00 AM UTC

Medium Hall(2nd Floor)

Chairman:Yuki Takamatsu(Takeda Pharmaceutical Co., Ltd.), Hisanori Hara(B2S Life Sciences)

[D1-A4]EBF Activities for the Future of Bioanalysis

Mon. Mar 3, 2025 5:00 PM - 5:30 PM JST
Mon. Mar 3, 2025 8:00 AM - 8:30 AM UTC

Medium Hall(2nd Floor)

Chairman:Takashi Miyayama(Chugai Pharmaceutical Co., Ltd.), Hisanori Hara(B2S Life Sciences)

[D1-A5]Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment

Mon. Mar 3, 2025 5:35 PM - 7:05 PM JST
Mon. Mar 3, 2025 8:35 AM - 10:05 AM UTC

Medium Hall(2nd Floor)

Chairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)

[D2-A1]Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment

Tue. Mar 4, 2025 9:10 AM - 10:10 AM JST
Tue. Mar 4, 2025 12:10 AM - 1:10 AM UTC

Medium Hall(2nd Floor)

Chairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)

[D2-A2]JSQA Collaboration Session: Issues and Recommendations for Promoting Data Integrity in GLP Facilities

Tue. Mar 4, 2025 3:25 PM - 4:55 PM JST
Tue. Mar 4, 2025 6:25 AM - 7:55 AM UTC

Medium Hall(2nd Floor)

Chairman:Noriyuki Koyama(Otsuka Pharmaceutical Co., Ltd.), Takeshi Okuzono(Sekisui Medical Co., Ltd.)

[D2-A3]Progress in bioanalysis using new technology of mass spectrometry

Tue. Mar 4, 2025 5:00 PM - 6:00 PM JST
Tue. Mar 4, 2025 8:00 AM - 9:00 AM UTC

Medium Hall(2nd Floor)

Chairman:Yohei Ohashi(Kyorin Pharmaceutical Co., Ltd.), Tsubasa Ibushi(Shimadzu Techno-Research, Inc.)

[D3-A1]Progress in bioanalysis using new technology of mass spectrometry

Wed. Mar 5, 2025 9:10 AM - 10:10 AM JST
Wed. Mar 5, 2025 12:10 AM - 1:10 AM UTC

Medium Hall(2nd Floor)

Chairman:Yohei Ohashi(Kyorin Pharmaceutical Co., Ltd.), Tsubasa Ibushi(Shimadzu Techno-Research, Inc.)

[D3-A2]Bioanalysis in Cellular and Gene Therapies: Standardization and Implementation

Wed. Mar 5, 2025 1:25 PM - 2:55 PM JST
Wed. Mar 5, 2025 4:25 AM - 5:55 AM UTC

Medium Hall(2nd Floor)

Chairman:Makoto Niwa(Nippon Shinyaku Co., Ltd.), Takeshi Hanada(Daiichi Sankyo Co., Ltd.)

[D3-A3]Hot topics related to ADC: New Approaches and Innovations

Wed. Mar 5, 2025 3:00 PM - 4:30 PM JST
Wed. Mar 5, 2025 6:00 AM - 7:30 AM UTC

Medium Hall(2nd Floor)

Chairman:Masanori Nagata(Astellas Pharma Inc.), Makoto Takahashi(Daiichi Sankyo Co., Ltd.)

[---]Closing Remarks

Wed. Mar 5, 2025 4:30 PM - 5:00 PM JST
Wed. Mar 5, 2025 7:30 AM - 8:00 AM UTC

Medium Hall(2nd Floor)

12 results ( 1 - 12 )

Back to Sessions